PROM1 and benign neoplasm: The study investigated the expression of CD133 protein in 83 LSCC specimens with follow-up data and the results indicated that CD133 protein expression level was positively correlative with grade of tumor (P = 0.001), lymph node metastasis (P < 0.001), and pTNM stage (P = 0.005).